WASHINGTON, DC: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla in the Oval Office of the White House as he announces a deal with Pfizer to lower drug prices on September 30, ...

LONDON, Oct 10 (Reuters) - Wall Street is looking to U.S. drugmaker Eli Lilly (LLY.N), opens new tab and Anglo-Swedish rival AstraZeneca (AZN.L), opens new tab as the potential next in line after ...

LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to ...

By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with ...

Ediitor's note: This article was updated at 7p ET with confirmation by the White House and additional details. President Trump Friday afternoon announced that AstraZeneca has made a deal with his ...

The president and top health officials acknowledged using the leverage of tariff threats to forge an agreement. Other companies are still in negotiations with the White House. By Rebecca Robbins and ...

The press conference that President Donald Trump hosted in the Oval Office with the CEO of drugmaker AstraZeneca on Friday played like a rerun of the late September Oval Office press conference with ...